Author

F. De Angelis Rigotti

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Fischer· 3 shared I. Moll· 3 shared J. Rodriguez-Vita· 3 shared L. Wiedmann· 3 shared E. Alsina-Sanchis· 2 shared M. Vacca· 2 shared R. Mülfarth· 2 shared A. Cerwenka· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

A. Fischer

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

HAPLN1 is a driver for peritoneal carcinomatosis in pancreatic cancer

L. Wiedmann, F. De Angelis Rigotti, N. Vaquero-Siguero, E. Donato, E. Espinet, I. Moll, E. Alsina-Sanchis, R. Mülfarth, M. Vacca, J. Gerwing, A. Trumpp, A. Fischer, J. Rodriguez-Vita

This study identifies HAPLN1 as a driver of peritoneal metastasis in pancreatic cancer by enhancing tumor cell plasticity and immunomodulation.

bioRxiv · May 30, 2022Cancer Biology

Endothelial Rbpj is essential for the education of tumour-associated macrophages

R. Mülfarth, E. Alsina-Sanchis, I. Moll, S. Böhn, L. Wiedmann, L. Jordana Urriza, T. Ziegelbauer, J. Taylor, F. De Angelis Rigotti, A. Stögbauer, B. D. Giaimo, A. Cerwenka, T. Borggrefe, A. Fischer, J. Rodriguez-Vita

This study shows that endothelial Rbpj promotes TAM education in EOC by regulating CXCL2, which drives CD44 expression and cholesterol depletion in TAMs, creating an immunosuppressive TME.

bioRxiv · Dec 20, 2021Cancer Biology

Semaphorin 3C exacerbates liver fibrosis

F. De Angelis Rigotti, L. Wiedmann, M. O. Hubert, M. Vacca, S. S. Hasan, I. Moll, S. Carvajal, W. Jimenez, M. Starostecka, A. T. Billeter, B. Müller-Stich, G. Wolff, B. Ekim-Üstünel, S. Herzig, C. Mogler, , J. Rodriguez-Vita

This study identifies SEMA3C as a key driver of liver fibrosis by enhancing TGF-β signaling in hepatic stellate cells.

bioRxiv · Jul 29, 2021Pathology